TUESDAY, Dec. 27, 2022 (HealthDay News) — Living in an area with easy access to parks and rivers appears to slow the progression of devastating neurological diseases, such as Alzheimer’s and Parkinson’s. That’s the conclusion of a new study based on more than a decade and a half tracking diseaseContinue Reading

THURSDAY, Dec. 22, 2022 (HealthDay News) — Ten children with an especially rare and hard-to-treat form of “bubble boy” disease are living normal lives after receiving a new gene therapy approach, researchers say. Experts said the findings are a major advance for children with the disease — a subtype ofContinue Reading

THURSDAY, Dec. 15, 2022 (HealthDay News) — Parkinson’s disease is a much bigger problem than previously thought, particularly for aging Americans, a new study finds. There are about 50% more new cases of the degenerative disorder diagnosed each year in North America than currently estimated, researchers concluded after an extensiveContinue Reading

TUESDAY, Nov. 8, 2022 (HealthDay News) — An experimental drug may help people with Parkinson’s disease find relief from constant constipation — a common and troublesome feature of the disease. In a trial involving 150 people with Parkinson’s and chronic constipation, researchers found that patients given the drug for aContinue Reading

TUESDAY, Nov. 8, 2022 (HealthDay News) — Women who have both ovaries removed before menopause may have a heightened risk of developing Parkinson’s disease years later, a new study suggests. Looking at decades of data on more than 5,000 women, researchers found that those who had both ovaries removed beforeContinue Reading

THURSDAY, Oct. 20, 2022 (HealthDay News) — The Black Death pandemic wiped out as many as half of the people living in some of the Middle Ages’ most densely populated places, sweeping through Europe, Asia and Africa nearly 700 years ago. Now genetic analysis has revealed why some of ourContinue Reading

MONDAY, Oct. 10, 2022 (HealthDay News) — Researchers report early success with using an existing rheumatoid arthritis (RA) drug to treat systemic sclerosis, a rare but potentially devastating autoimmune condition. The disease, a subset of scleroderma, hardens the skin and affects internal organs, but no approved treatment for it exists.Continue Reading

FRIDAY, Oct. 7, 2022 (HealthDay News) — New research suggests you can add rugby players to the list of professional athletes who face a significantly heightened risk of brain diseases following years of intense contact play. “This latest work under our FIELD program of research demonstrates that risk of neurodegenerativeContinue Reading

WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports. After lengthy COVID infections, two kidney transplant patients on immune-suppressing drugs to prevent organ rejection developed a mutated version of SARS-CoV-2 resistantContinue Reading